PCSK9 and stroke disorder: The aim of this review is to provide an in-depth understanding of the action mechanisms, efficacy and safety of PCSK-9 inhibitors in targeting high LDL-C levels for the primary and secondary prevention of acute ischemic stroke, as well as to present the future directions regarding the use of this therapy for the management of stroke patients.